Dietary Salt Accelerates Orthodontic Tooth Movement by Increased Osteoclast Activity.
Alveolar Bone Loss
/ metabolism
Animals
Bone Density
Bone Remodeling
Male
Mice
Osteoclasts
/ cytology
Osteogenesis
Periodontal Ligament
/ metabolism
RAW 264.7 Cells
Sodium Chloride, Dietary
/ metabolism
Tartrate-Resistant Acid Phosphatase
/ metabolism
Tooth Migration
/ metabolism
Transcription Factors
/ metabolism
orthodontic tooth movement
osteoclast activity
salt
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
09 Jan 2021
09 Jan 2021
Historique:
received:
18
11
2020
revised:
14
12
2020
accepted:
01
01
2021
entrez:
13
1
2021
pubmed:
14
1
2021
medline:
8
9
2021
Statut:
epublish
Résumé
Dietary salt uptake and inflammation promote sodium accumulation in tissues, thereby modulating cells like macrophages and fibroblasts. Previous studies showed salt effects on periodontal ligament fibroblasts and on bone metabolism by expression of nuclear factor of activated T-cells-5 (NFAT-5). Here, we investigated the impact of salt and NFAT-5 on osteoclast activity and orthodontic tooth movement (OTM). After treatment of osteoclasts without (NS) or with additional salt (HS), we analyzed gene expression and the release of tartrate-resistant acid phosphatase and calcium phosphate resorption. We kept wild-type mice and mice lacking NFAT-5 in myeloid cells either on a low, normal or high salt diet and inserted an elastic band between the first and second molar to induce OTM. We analyzed the expression of genes involved in bone metabolism, periodontal bone loss, OTM and bone density. Osteoclast activity was increased upon HS treatment. HS promoted periodontal bone loss and OTM and was associated with reduced bone density. Deletion of NFAT-5 led to increased osteoclast activity with NS, whereas we detected impaired OTM in mice. Dietary salt uptake seems to accelerate OTM and induce periodontal bone loss due to reduced bone density, which may be attributed to enhanced osteoclast activity. NFAT-5 influences this reaction to HS, as we detected impaired OTM and osteoclast activity upon deletion.
Identifiants
pubmed: 33435280
pii: ijms22020596
doi: 10.3390/ijms22020596
pmc: PMC7827744
pii:
doi:
Substances chimiques
Nfat5 protein, mouse
0
Sodium Chloride, Dietary
0
Transcription Factors
0
Tartrate-Resistant Acid Phosphatase
EC 3.1.3.2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : German Research Foundation DFG
ID : SCHR 1622/1-1 and KI 2105/2-1
Organisme : German Orthodontic Society DGKFO
ID : Kirschneck 2018
Références
Osteoporos Int. 2017 Nov;28(11):3215-3228
pubmed: 28849275
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
J Dent Res. 2009 Jul;88(7):597-608
pubmed: 19641146
J Dent Res. 1954 Aug;33(4):481-6
pubmed: 13184036
J Clin Invest. 1997 Aug 1;100(3):538-49
pubmed: 9239400
J Clin Invest. 2017 May 1;127(5):1932-1943
pubmed: 28414302
Curr Opin Nephrol Hypertens. 2010 Jul;19(4):385-92
pubmed: 20571401
J Dent Res. 2015 Sep;94(9):1286-94
pubmed: 26124217
J Clin Invest. 2017 May 1;127(5):1944-1959
pubmed: 28414295
Immunol Cell Biol. 2021 Jan;99(1):84-96
pubmed: 32888231
Bone Res. 2013 Mar 29;1(1):11-26
pubmed: 26273491
Eur J Orthod. 2006 Jun;28(3):221-40
pubmed: 16687469
Innate Immun. 2016 Nov;22(8):674-681
pubmed: 28071181
Eur J Oral Sci. 2019 Oct;127(5):386-395
pubmed: 31254476
Pflugers Arch. 2017 Feb;469(2):225-233
pubmed: 27942992
Science. 2000 Sep 1;289(5484):1501-4
pubmed: 10968779
J Biomed Mater Res B Appl Biomater. 2014 Jul;102(5):903-12
pubmed: 24259122
J Hypertens. 2004 Apr;22(4):803-10
pubmed: 15126923
J Orofac Orthop. 2018 Sep;79(5):337-351
pubmed: 30019109
Bone. 2010 Aug;47(2):331-40
pubmed: 20441802
J Orofac Orthop. 2020 Sep;81(5):360-370
pubmed: 32632652
Cell. 1998 Apr 17;93(2):165-76
pubmed: 9568710
Oral Dis. 2015 Sep;21(6):694-704
pubmed: 25040955
J Clin Invest. 2015 Nov 2;125(11):4223-38
pubmed: 26485286
J Biol Chem. 1997 Oct 3;272(40):25190-4
pubmed: 9312132
Nat Rev Nephrol. 2020 Jun;16(6):352-364
pubmed: 32157251
Science. 2000 Sep 1;289(5484):1504-8
pubmed: 10968780
JCI Insight. 2019 Dec 5;4(23):
pubmed: 31801906
Cell Metab. 2015 Mar 3;21(3):493-501
pubmed: 25738463
Curr Genomics. 2010 Dec;11(8):584-90
pubmed: 21629436
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Nat Med. 2009 May;15(5):545-52
pubmed: 19412173
Arch Biochem Biophys. 2008 May 15;473(2):139-46
pubmed: 18395508
Nat Rev Immunol. 2019 Oct;19(10):626-642
pubmed: 31186549
J Clin Invest. 2013 Jul;123(7):2803-15
pubmed: 23722907